<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ciprofloxacin and dexamethasone: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ciprofloxacin and dexamethasone: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Ciprofloxacin and dexamethasone: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="9290" href="/d/html/9290.html" rel="external">see "Ciprofloxacin and dexamethasone: Drug information"</a> and <a class="drug drug_patient" data-topicid="10851" href="/d/html/10851.html" rel="external">see "Ciprofloxacin and dexamethasone: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F151783"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Ciprodex [DSC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52911951"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Ciprodex;</li>
<li>SANDOZ Ciprofloxacin/Dexametha</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1046320"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antibiotic/Corticosteroid, Otic</span></li></ul></div>
<div class="block dop drugH1Div" id="F151792"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a96b8104-65d0-48ba-b460-4308464e6db6">Otitis media, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, acute (with tympanostomy tubes):</b> Infants ≥6 months, Children, and Adolescents: Otic: Instill 4 drops into affected ear(s) twice daily for 7 days</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f5d6908b-d92c-483f-9021-2db65a1a0811">Otitis externa, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis externa, acute:</b> Infants ≥6 months, Children, and Adolescents: Otic: Instill 4 drops into affected ear(s) twice daily for 7 days</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51084784"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">Infants ≥6 months, Children, and Adolescents: There are no dosing adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51084785"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">Infants ≥6 months, Children, and Adolescents: There are no dosing adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F151784"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9290" href="/d/html/9290.html" rel="external">see "Ciprofloxacin and dexamethasone: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f5d6908b-d92c-483f-9021-2db65a1a0811">Otitis externa, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis externa, acute:</b>
<b>Otic:</b> Instill 4 drops into affected ear(s) twice daily for 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MANU.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MANU.1'])">Ref</a></span>); may extend treatment an additional 7 days if symptoms are improving but not yet resolved (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24491310']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24491310'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50989982"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doha drugH1Div" id="F50987330"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block adr drugH1Div" id="F151764"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Adverse reaction reported in pediatric patients and adults. Also see individual agents.</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Pruritus of ear (≤2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Otic: Otalgia (≤3%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Dysgeusia, oral candidiasis</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Superinfection</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Dizziness, irritability, tingling of the ears</p>
<p style="text-indent:-2em;margin-left:4em;">Otic: Ear redness; ear residue, debris, or precipitate; eustachian tube congestion; hearing loss; tinnitus; tympanostomy tube blockage</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Erythematous rash, exfoliation of skin</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Vomiting</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Hypersensitivity reaction</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Headache</p>
<p style="text-indent:-2em;margin-left:4em;">Otic: Swelling of the ear</p></div>
<div class="block coi drugH1Div" id="F151775"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity to ciprofloxacin, other fluoroquinolones, dexamethasone, or any component of the formulation; viral infection of the external canal, including herpes simplex infections; fungal otic infections.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Canadian labeling:</i> Additional contraindications (not in US labeling): Hypersensitivity to other corticosteroids; parasitic otic infections.</p></div>
<div class="block war drugH1Div" id="F151762"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Hypersensitivity: Severe and occasionally fatal hypersensitivity reactions, including anaphylaxis, have occurred with systemic fluoroquinolone therapy.  Prompt discontinuation of drug should occur if skin rash or other symptoms of hypersensitivity arise. </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Superinfection: Prolonged use may result in fungal or bacterial superinfection. If superinfection occurs, discontinue use and institute appropriate therapy.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Tendon inflammation/rupture:  There have been reports of tendon inflammation and/or rupture with systemic fluoroquinolones.  Exposure following otic administration is substantially lower than with systemic therapy.  Discontinue at first sign of tendon inflammation or pain.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Appropriate use: For otic use only; not intended for injection or ophthalmic use. Prior to instillation, suspension should be warmed in hands to prevent dizziness, which may occur following use of a cold solution.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878386"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">In pediatric patients, use of quinolone ear drops after tympanostomy tube placement may increase the risk of tympanic rupture. A retrospective cohort study of over 96,000 patients (&lt;18 years of age) compared patients who received a quinolone-containing ear drop (n=78,275) to those who received a neomycin plus hydrocortisone ear drop (n=18,320). Patients who received quinolone ear drops after tympanostomy tube placement had an increased incidence of tympanic perforation requiring tympanoplasty with an adjusted hazard ratio of 1.61 (95% confidence interval [CI]: 1.15 to 2.26); combination products containing corticosteroids may amplify adverse effect risk; monitor and counsel patients accordingly (Alrawisan 2017)</p></div>
<div class="block foc drugH1Div" id="F151770"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension, Otic: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ciprodex: Ciprofloxacin 0.3% and dexamethasone 0.1% (7.5 mL [DSC]) [contains benzalkonium chloride, edetate (edta) disodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ciprodex: Ciprofloxacin 0.3% and dexamethasone 0.1% (7.5 mL [DSC]) [contains benzalkonium chloride, edetate (edta) disodium, tyloxapol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Ciprofloxacin 0.3% and dexamethasone 0.1% (7.5 mL)</p></div>
<div class="block geq drugH1Div" id="F151760"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F3422207"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Ciprofloxacin-dexAMETHasone Otic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.3-0.1% (per mL): $35.87 - $37.36</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F53482934"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension, Otic: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ciprodex: Ciprofloxacin 0.3% and dexamethasone 0.1% (7.5 mL) [contains benzalkonium chloride, edetate (edta) disodium, tyloxapol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Ciprofloxacin 0.3% and dexamethasone 0.1% (7.5 mL)</p></div>
<div class="block admp drugH1Div" id="F52612423"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">For otic use only. To avoid dizziness which may result from the instillation of a cold solution, warm bottle in hand for 1 to 2 minutes prior to use. Shake suspension well before using; avoid contamination of the tip of the bottle to fingers, ear, or any surfaces. Patient should lie with affected ear upward and maintain position for 60 seconds after suspension is instilled.</p>
<p style="text-indent:-2em;margin-left:2em;">Acute otitis media with tympanostomy tubes: Instill drops then gently press the tragus 5 times in a pumping motion to allow the drops to pass through the tube into the middle ear.</p>
<p style="text-indent:-2em;margin-left:2em;">Acute otitis externa: Gently pull the outer ear lobe upward and backward to allow the drops to flow down into the ear canal.</p></div>
<div class="block adm drugH1Div" id="F151772"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Otic:</b> For otic use only; not intended for injection or ophthalmic use. Prior to instillation, bottle should be warmed in hands for 1 to 2 minutes; dizziness can occur if a cold suspension is instilled. Shake suspension well immediately before using. Patient should lie with affected ear upward and remain in this position for 60 seconds following application.</p>
<p style="text-indent:-2em;margin-left:2em;">Acute otitis media with tympanostomy tubes: Instill drops then gently press the tragus 5 times in a pumping motion to allow the drops to pass through the tube into the middle ear.</p>
<p style="text-indent:-2em;margin-left:2em;">Acute otitis externa: Gently pull the outer ear lobe upward and backward to allow the drops to flow down into the ear canal.</p></div>
<div class="block sts drugH1Div" id="F151781"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store at  20°C to 25°C (68°F to 77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F); avoid freezing. Protect from light.</p></div>
<div class="block usep drugH1Div" id="F53566066"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Treatment of acute otitis media in patients with tympanostomy tubes (FDA approved in ages ≥6 months to 18 years); treatment of acute otitis externa (FDA approved in ages ≥6 months and adults)</p></div>
<div class="block cyt drugH1Div" id="F13299047"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F151765"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F151776"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Ciprofloxacin and dexamethasone have minimal systemic absorption following otic administration, limiting any potential exposure to the fetus.</p></div>
<div class="block mopp drugH1Div" id="F53566040"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Resolution of infection; if infection persists after 1 week of treatment, obtain cultures to guide further treatment. If otorrhea persists after a full course of therapy, or if ≥2 episodes occur within 6 months, evaluate to exclude an underlying condition (eg, cholesteatoma, foreign body, tumor)</p></div>
<div class="block pha drugH1Div" id="F151761"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:-2em;margin-left:2em;">Ciprofloxacin: Inhibits DNA-gyrase in susceptible organisms; inhibits relaxation of supercoiled DNA and promotes breakage of double-stranded DNA.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Dexamethasone: Decreases inflammation by suppression of neutrophil migration, decreased production of inflammatory mediators, and reversal of increased capillary permeability; suppresses normal immune response.</p></div>
<div class="block phk drugH1Div" id="F151774"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Absorption: Otic: Ciprofloxacin: Peak: 0.1% of oral administration peak concentrations; Dexamethasone: Peak: 14% of oral administration peak concentrations</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Time to peak, plasma: Otic: 15 minutes to 2 hours</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F854898"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Ciloxadex | Cirflox Oftal | Decadron con ciprofloxacina | Fotamicin | Omaflaxina d | Polex</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Cilodex</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Cilodex | Ciprodex | Dexacort c | Poenbiotic</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Alcon cilodex | Ciprofloxacina + dexametasona | Cixol | Fixamicin dexacipro | Flobact-d | Meodex | Ocubrax | Oq cort | Otiker</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Cilodex</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Ciprodex | Ciprodexal | Deciprox | Poenbiotic</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Ciprodex | Fixamicin dexacipro</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Dropiflox</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Cilodex | Ciprofloxacin/dexamethasone</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Cilodex</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Cilodex</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Cilodex | Ciprodex | Ciproxxak | Flobact-d</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Dexcip</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Ciprodex | Ciprofloxacin 0,3% and dexamethasone 0,1% | Ciprofloxacin 0.3% and dexamethasone 0.1% | Ciprofloxacin/dexamethasone</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Cilodex | Ciprodex | Ciprodex otico | Poenbiotic</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Okomix</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Cilodex | Ciprodex</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-28329128">
<a name="28329128"></a>Alrwisan A, Antonelli PJ, Winterstein AG. Quinolone ear drops after tympanostomy tubes and the risk of eardrum perforation: a retrospective cohort study. <i>Clin Infect Dis</i>. 2017;64(8):1052-1058.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciprofloxacin-and-dexamethasone-pediatric-drug-information/abstract-text/28329128/pubmed" id="28329128" target="_blank">28329128</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Ciprodex.1">
<a name="Ciprodex.1"></a>Ciprodex (ciprofloxacin/dexamethasone) otic suspension [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; November 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CiprodexCAN.1">
<a name="CiprodexCAN.1"></a>Ciprodex (ciprofloxacin and dexamethasone) [product monograph]. Dorval, Quebec, Canada: Novartis Pharmaceuticals Canada Inc; September 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-MANU.1">
<a name="MANU.1"></a>Refer to manufacturer’s labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24491310">
<a name="24491310"></a>Rosenfeld RM, Schwartz SR, Cannon CR, et al. Clinical practice guideline: acute otitis externa. <i>Otolaryngol Head Neck Surg.</i> 2014;150(suppl 1):S1-S24. doi:10.1177/0194599813517083<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciprofloxacin-and-dexamethasone-pediatric-drug-information/abstract-text/24491310/pubmed" id="24491310" target="_blank">24491310</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 12922 Version 186.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
